INTERNATIONAL PATENT: ONCOMATRYX BIOPHARMA S.L. FILES APPLICATION FOR "FAP-TARGETED ANTIBODY-DRUG CONJUGATES"

GENEVA, Feb. 2 -- ONCOMATRYX BIOPHARMA S.L. (801-B PARQUE TECNOLOGICO DE BIZKAIADERIO Vizcaya) filed a patent application (PCT/EP2025/070916) for "FAP-TARGETED ANTIBODY-DRUG CONJUGATES" on Jul 21, 2025. With publication no. WO/2026/022112, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EGAÑA GANUZA, Isabel (c/o Oncomatryx Biopharma S.L.801-B PARQUE TECNOLOGICO DE BIZKAIADERIO Vizcaya), ALDABA AREVALO, Eneko (c/o Oncomatryx Biopharma S.L.801-B PARQUE TECNOLOGICO DE BIZKAIADERIO Vizcaya), VARA SALAZAR, Yosu Ion (c/o O...